If I develop COVID-19 symptoms during the treatment, what will happen?
ARCS and BFS Guideline
If a patient or donor develops symptoms suggestive of coronavirus or screens positive on the questionnaire during treatment, an antigen screen should be arranged and treatment should not proceed unless the patient screens negative as defined by national guidelines.
In the event of a patient or donor presenting with suspected or confirmed COVID-19 after the ovulatory trigger, a multidisciplinary individual risk assessment should take place to balance the risks of refraining from oocyte retrieval against those of proceeding.
At present there is little data on the risks of minor surgical procedures in women with a diagnosis of COVID-19. Patients who become symptomatic after oocyte retrieval but prior to embryo transfer should be advised to freeze all their embryos for future use.
Gynii Me's Suggestion
If you or a member of your household have any symptoms, we suggest you do not seek an immediate treatment date. You can still contact your clinic to start your cycle in 4-6 weeks assuming you don’t have any ongoing symptoms. Further advice on COVID-19 symptoms can be found here.